BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc.

LipoMedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that Phase 1 data of Promitil® (PL-MLP) in patients with metastatic colorectal cancer (CRC) was published in the research journal Investigational New Drugs

Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter and full-year ended December 31, 2019 on Monday, February 10, 2020 after the market close.

Lively, Inc., creators of the modern Health Savings Account (HSA), today released its second annual HSA Spend Report, giving a view into how and where consumers spend on healthcare costs each year

Freenome, a privately-held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection through a routine blood draw, is presenting data from their prospective, multi-center clinical study AI-EMERGE®

Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. (“Synthorx”) for $68 per share in cash.

Medtronic plc (NYSE:MDT) today announced that it received approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the safety and effectiveness of the PulseSelect™ Pulsed Field Ablation (PFA) System, a new technology that uses pulsed electric fields to treat atrial fibrillation

PrimaryPlus (https://primaryplus.net) and PursueCare (https://www.pursuecare.com) today announced that they have partnered to launch an integrated telehealth addiction and behavioral health treatment model serving rural populations across PrimaryPlus’ Kentucky footprint which includes seven health center locations.

Nationally renowned cardiovascular surgeons Marc Sakwa, M.D. and Jeffrey Altshuler, M.D. are bringing their leadership, surgical advancements and world-class expertise in minimally invasive heart surgery for complex heart procedures to MemorialCare Heart & Vascular Institute

POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis, announced the appointment of David E. Moller, MD, as Chief Scientific Officer.